Clinical Trials List
2022-08-01 - 2029-06-04
Phase II/III
Recruiting5
ICD-10N05.9
Unspecified nephritic syndrome with unspecified morphologic changes
ICD-9583.0
Nephritis and nephropathy, not specified as acute or chronic, with lesion of proliferative glomerulonephritis
-
Trial Applicant
GEORGE CLINICAL ASIA PACIFIC LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHUN-FU LAI Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chin Lee Division of Nephrology
- Jin-Bor Chen Division of Nephrology
- 邱千華 Division of Nephrology
- 楊智超 Division of Nephrology
- 李隆志 Division of Nephrology
- 黃鏘錡 Division of Nephrology
- 許淳惟 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mei-Yi Wu Division of Nephrology
- Chia-Te Liao Division of Nephrology
- Li-Yee Hong Division of Nephrology
- I-WEN WU Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
19 participants
-
Global
600 participants
